Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group

The Age-Related Macular Degeneration Study-Krypton Laser (AMDS-K) is a multicenter controlled clinical trial designed to determine whether krypton red laser photocoagulation is of value in preventing visual acuity loss in eyes with macular degeneration that have either choroidal neovascularization 1 to 199 microns from the center of the foveal avascular zone or choroidal neovascularization 200 microns or farther from the foveal avascular zone center with blood and/or blocked fluorescence extending within 200 microns of the foveal avascular zone center. Recruitment ended in December 1987 after 247 patients had been assigned to photocoagulation and 249 patients had been assigned to no treatment. At 3 years after randomization, 49% (86/174) of treated eyes, in contrast to 58% (98/169) of untreated eyes, had lost six or more lines of visual acuity. The average visual acuity of treated and untreated eyes at that time was 20/200 and 20/250, respectively. The benefit of laser treatment was largest among patients without evidence of hypertension and diminished to no apparent benefit among patients who had highly elevated blood pressure and/or used antihypertensive medication. Treatment of lesions meeting the AMDS-K eligibility criteria in eyes of patients with no hypertension is recommended. However, treatment cannot be recommended uniformly for patients with definite hypertension having lesions similar to those of patients enrolled in the AMDS-K.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Lesion morphology in age-related macular degeneration and its therapeutic significance.
Beaumont and Kang
Arch Ophthalmol 2006;124:807-812.
ABSTRACT | FULL TEXT  

Ultrahigh resolution optical coherence tomography in non-exudative age related macular degeneration
Pieroni et al.
Br. J. Ophthalmol. 2006;90:191-197.
ABSTRACT | FULL TEXT  

Large-Spot Size Transpupillary Thermotherapy for the Treatment of Occult Choroidal Neovascularization Associated With Age-Related Macular Degeneration
Thach et al.
Arch Ophthalmol 2003;121:817-820.
ABSTRACT | FULL TEXT  

Retinal Pigment Epithelium Wound Healing in Human Bruch's Membrane Explants
Wang et al.
IOVS 2003;44:2199-2210.
ABSTRACT | FULL TEXT  

A Randomized Clinical Trial of a Single Dose of Intravitreal Triamcinolone Acetonide for Neovascular Age-Related Macular Degeneration: One-Year Results
Gillies et al.
Arch Ophthalmol 2003;121:667-673.
ABSTRACT | FULL TEXT  

Responsiveness of the National Eye Institute Visual Function Questionnaire to Changes in Visual Acuity: Findings in Patients With Subfoveal Choroidal Neovascularization--SST Report No. 1
The Submacular Surgery Trials Research Group
Arch Ophthalmol 2003;121:531-539.
ABSTRACT | FULL TEXT  

Eligibility for treatment and angiographic features at the early stage of exudative age related macular degeneration
Haddad et al.
Br. J. Ophthalmol. 2002;86:663-669.
ABSTRACT | FULL TEXT  

Clinicopathologic Correlation of Idiopathic Polypoidal Choroidal Vasculopathy
Rosa et al.
Arch Ophthalmol 2002;120:502-508.
FULL TEXT  

Short-Term Study of Allogeneic Retinal Pigment Epithelium Transplants onto Debrided Bruch's Membrane
Wang et al.
IOVS 2001;42:2990-2999.
ABSTRACT | FULL TEXT  

Yellow dye laser thermotherapy of choroidal neovascularisation in age related macular degeneration
Beintema et al.
Br. J. Ophthalmol. 2001;85:708-713.
ABSTRACT | FULL TEXT  

The Age-Related Eye Disease Study: A Clinical Trial of Zinc and Antioxidants--Age-Related Eye Disease Study Report No. 2
Group
J. Nutr. 2000;130:1516S-1519.
ABSTRACT | FULL TEXT  

Foveal relocation by redistribution of the neurosensory retina
Wong and Lois
Br. J. Ophthalmol. 2000;84:352-357.
ABSTRACT | FULL TEXT  

Hypertension, Cardiovascular Disease, and Age-Related Macular Degeneration
Hyman et al.
Arch Ophthalmol 2000;118:351-358.
ABSTRACT | FULL TEXT  

Long term results of radiotherapy for subfoveal choroidal neovascularisation in age related macular degeneration
Chiquet et al.
Br. J. Ophthalmol. 1999;83:923-928.
ABSTRACT | FULL TEXT  

Indocyanine green angiographic features prognostic of visual outcome in the natural course of patients with age related macular degeneration
Obana et al.
Br. J. Ophthalmol. 1999;83:429-437.
ABSTRACT | FULL TEXT  

Alternative therapies in exudative age related macular degeneration
CHONG and BIRD
Br. J. Ophthalmol. 1998;82:1441-1443.
FULL TEXT  

A Model of the Incidence and Consequences of Choroidal Neovascularization Secondary to Age-related Macular Degeneration: Comparative Effects of Current Treatment and Potential Prophylaxis on Visual Outcomes in High-Risk Patients
Lanchoney et al.
Arch Ophthalmol 1998;116:1045-1052.
ABSTRACT | FULL TEXT  

Decreased choriocapillaris perfusion following surgical excision of choroidal neovascular membranes in age-related macular degeneration
Nasir et al.
Br. J. Ophthalmol. 1997;81:481-489.
ABSTRACT | FULL TEXT  

Diseases of the Retina
D'Amico
NEJM 1994;331:95-106.
FULL TEXT